Immunology
5 drugs are in development for Hereditary Angioedema.
- Companies
- 3
- Clinical trials
- 26
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Hereditary Angioedema pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
Phase 2(1)
| Drug | Company |
|---|---|
| STAR-0215 | Astria Therapeutics, Inc. (ATXS) |
Phase 4(1)
| Drug | Company |
|---|---|
| sebetralstat odt | KalVista Pharmaceuticals, Inc. (KALV) |
About this indication
Hereditary Angioedema context
Immunology·MeSH: Angioedemas, Hereditary (D054179)
Also known as: Angioneurotic Edemas, Hereditary, C1 Esterase Inhibitor Deficiency, C1 Inhibitor Deficiency, Edema, Hereditary Angioneurotic, Hereditary Angioedemas
Compare drugs
Frequently asked questions
How many drugs are in development for Hereditary Angioedema?
BioSniper tracks 5 drugs in development for Hereditary Angioedema across 3 companies.
How many clinical trials target Hereditary Angioedema?
There are 26 clinical trials targeting Hereditary Angioedema tracked by BioSniper.